IRIS
GERMANI, MASSIMILIANO ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 522
EU - Europa 390
AS - Asia 255
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
Totale 1.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 514
CN - Cina 250
IE - Irlanda 139
UA - Ucraina 85
DE - Germania 48
FI - Finlandia 44
SE - Svezia 30
GB - Regno Unito 14
IT - Italia 11
BE - Belgio 8
CA - Canada 8
FR - Francia 8
BR - Brasile 4
EU - Europa 4
GR - Grecia 2
IL - Israele 2
KR - Corea 2
KZ - Kazakistan 1
NL - Olanda 1
Totale 1.175
Salva come PNG Salva come JPEG
Città #
Dublin 137
Chandler 133
Jacksonville 99
Nanjing 64
Beijing 43
Ann Arbor 31
New York 30
Nanchang 27
Ashburn 21
Hebei 20
Shenyang 20
Tianjin 19
Princeton 18
Lawrence 17
Boardman 14
Medford 14
Wilmington 14
Jiaxing 13
Dearborn 11
Helsinki 10
Changsha 9
Hangzhou 9
Shanghai 9
Woodbridge 9
Brussels 8
Piscataway 6
Los Angeles 5
Toronto 5
Kunming 4
Milan 4
Norwalk 4
Houston 3
Seattle 3
Verona 3
Zhengzhou 3
Fairfield 2
Netanya 2
Ningbo 2
Washington 2
Winnipeg 2
Amsterdam 1
Changchun 1
Des Moines 1
Fuzhou 1
Grugliasco 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Henderson 1
Lanzhou 1
Lodi Vecchio 1
Pavia 1
Taizhou 1
Walnut 1
Totale 863
Salva come PNG Salva come JPEG
Nome #
A non parametric population approach for selecting biomarkers of a drug action 94
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 86
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 79
A Bayesian approach to non-parametric AUC estimation in population studies 78
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 74
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 73
Modeling myelosuppression in patients treated with anticancer drugs 72
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 70
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 68
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 67
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 66
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 66
A tumor growth inhibition model in drugs combination regimens 66
Statistical methods to detect immune responses to drug administration 62
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts 57
Re: Antitumor Efficacy Testing in Rodents 55
A model based approach to the in vitro evaluation of anticancer activity 50
Totale 1.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.235
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 0 8
2019/2020307 68 113 0 19 1 19 7 22 7 29 22 0
2020/2021156 21 16 4 20 0 20 2 20 4 22 23 4
2021/202283 4 2 5 1 2 0 1 6 3 5 14 40
2022/2023363 34 40 3 25 41 33 1 21 148 3 10 4
2023/2024108 6 7 9 12 5 47 0 10 0 4 8 0
Totale 1.183